All Type of News
20 modified versions of older drugs approved in 4 years
A total of 20 prescription drugs approved by the Ministry of Food and Drug Safety (MFDS) between 2009 and 2012 were modified versions of existing medicines, or identical to drugs already on the market.
According to...
Drug makers call for realistic support
Pharmaceutical firms are calling for the government to provide them with more practical and realistic support, criticizing too many restrictions on the industry.
Without such efforts, the government’s plan for Kore...
Korean drugmakers challenge Glivec in generics fight
Korean pharmaceutical firms are gearing up to enter the 100 billion won leukemia drug market as the main patent of the market leader, Novartis’s Glivec (imatinib), is to expire on June 3, allowing for generic versions...
Suspension of Glivec’s patient assistance program under fire from patients
The suspension of Glivec’s assistance program for people suffering from chronic myelogenous leukemia (CML) has sparked outrage and disappointment.
In a meeting with CML patients on May 13, Novartis Korea informed t...
14 drugmakers shell out 37.5 billion won in new broadcasting media
Korea’s fourteen pharmaceutical companies have been spending on the four new general programming channels and other broadcasting media that debuted in late 2011.
Citing the 2013 business report released by the Fina...
Dong-A’s illegal kickbacks revealed
A former employee of Dong-A Pharmaceutical testified in Monday’s court hearing that he had offered the illegal rebate of 2.4 million won to a doctor per a 15-minute educational video in an effort to prescribe or sell ...
Former health minister to head national pension serviceThe Ministry of Health and Welfare said last Friday that President Park Geun-hye has named former Health Minister Choi Kwang to head the National Pension Service.
Choi, 66, r...
|
Drugmakers call for pro-R&D policies
The domestic pharmaceutical industry may become one of the new growth engines for the Korean economy, but it there are still many challenges to overcome, such as a lack of incentives to attract domestic and foreign ph...
Three persons to face testimony over Dong-A’s illegal kickbacks
The Seoul Central District Court will call three witnesses in testimony today in its third trial in a bid to examine whether some doctors, who allegedly took kickbacks from Dong-A Pharmaceutical, received money in ret...
Pharmacy colleges will benefit from local university promotion plan
The Korean Council for University Education (KCUE) on Thursday unveiled its plan to promote local university education, which will give a positive sign to pharmacy colleges in the provinces.
In a policy-making foru...
